Nadeem Riaz

Papers

Total Citations

H-Index

About

Nadeem Riaz is a leading radiation oncologist and researcher whose work centers on HPV-associated oropharyngeal cancer (OPC), treatment deintensification, and the integration of genomics into radiotherapy. His major contributions include shaping clinical paradigms for reducing long-term toxicities in HPV-positive OPC patients, a population with favorable prognosis but high susceptibility to chemoradiation-related morbidities. His highly cited 2022 consensus paper, with 57 citations, navigates the controversies and future directions in deintensification strategies, directly influencing how clinicians balance cure rates with quality of life. Riaz’s impact extends beyond clinical guidelines; he has pioneered the use of liquid biopsies and radiogenomics to personalize treatment, identifying biomarkers that predict response and resistance. His work has garnered over 10,000 citations, reflecting its profound influence on head and neck oncology. Notably, he has led key trials exploring de-escalation and has been recognized with awards from the American Society for Radiation Oncology (ASTRO). For students and researchers, Riaz exemplifies how translational research can bridge molecular insights with practical, patient-centered care, offering a roadmap for reducing treatment burden without compromising outcomes.